
Morningstar posted Q1 2026 reported revenue of $644.8 million, up 10.8%, with adjusted operating income rising 31.9% to $178.6 million and margins expanding to 27.7%. The company is aggressively buying back stock, repurchasing more than $1.1 billion over the trailing twelve months and cutting shares by over 10%, while total index-linked assets exceeded $4.2 trillion after the CRSP acquisition. Key headwinds remain PitchBook growth slowing to 5.3%, leverage rising to 2.0x debt/EBITDA, and AI pressure on commoditized data, but the article argues the current valuation around 17x forward earnings is attractive.
The market is still pricing MORN like a structurally slower data vendor, but the second-order effect is that buybacks are now the dominant earnings catalyst, not just a capital return footnote. Once leverage normalizes, every incremental dollar of free cash flow can be recycled into a shrinking float, which means per-share growth can outpace the underlying business even if PitchBook stays mid-single digit. That makes the stock unusually sensitive to execution on capital allocation: a modest beat in credit, retirement, or indexes can translate into a disproportionate EPS re-rating because the denominator is falling so fast. The more interesting competitive dynamic is that Morningstar is becoming less exposed to the "search and summarize" layer where AI can commoditize value, and more exposed to regulated, embedded, and benchmarked workflows where AI is mostly additive. That widens the gap versus lower-moat research tools and even some larger peers that have stronger brand power but slower product iteration. CRSP is especially important here: index-linked AUM creates a quasi-annuity stream that benefits from market beta and fund flows without needing VC recovery, so the business mix is quietly becoming less cyclical than the headline PitchBook narrative suggests. The main risk is not a collapse in the franchise but a pause in the buyback engine if debt markets tighten or management gets more conservative around 2x leverage. That would likely cap near-term upside over the next 2-3 quarters even if fundamentals remain healthy. Conversely, any stabilization in PitchBook growth or continued margin expansion toward 30% would likely trigger a sharp multiple reset higher because the stock is being valued as if current margin gains are peak rather than early-cycle. Consensus is missing that this is not a single-bet on PitchBook recovery; it is a multi-year per-share compounding story with optionality from credit, retirement, and indexes. At ~17x forward earnings, the stock is cheap relative to its own history, but the deeper mispricing is the market underestimating how quickly a 5-6% annual float reduction can compound intrinsic value when paired with high-visibility recurring revenue. The path to 20-23x is not heroic growth; it is simply the market accepting that the current downturn in sentiment is not structural impairment.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment